Vancomycin resistance mutations enable bacteria to grow in the presence of vancomycin, but they do so at a cost. Vancomycin-resistant S. aureus (VRSA) strains grow more slowly and will often lose ...

Staphylococcus aureus has the potential to develop durable vancomycin resistance, according to a new study. Staphylococcus aureus has the potential to develop durable vancomycin resistance, according ...

Clostridioides difficile (C. difficile) is a leading cause of illness and death, especially for frail and hospitalized Americans. Now, a new study suggests that the leading antibiotic used to fight it ...

Amneal Pharmaceuticals is recalling four lots of an antibacterial after a manufacturing error may have resulted in overfilled bottles. The recall covers four ...

Please provide your email address to receive an email when new articles are posted on . Results showed use of IV vancomycin was linked with a higher periprosthetic joint infection risk vs. use of ...

In patients with suspected sepsis, the use of β-lactam therapy prior to vancomycin was associated with lower risk of in-hospital mortality compared with vancomycin prior to β-lactam therapy. The ...

The concomitant use of vancomycin and piperacillin-tazobactam has been the focus of increasing clinical scrutiny due to its association with acute kidney injury (AKI). Vancomycin, a potent ...

People believed to have sepsis who take piperacillin-tazobactam (Zosyn) and vancomycin have a 5% absolute mortality increase at 90 days compared with those who take cefepime and vancomycin, a new ...

LEDGEWOOD, N.J.--(BUSINESS WIRE)--ImprimisRx, America’s #1 Ophthalmic Pharmacy™, today announced the availability of Fortisite™, which includes a patent-pending compounded combination of Tobramycin ...